9 Reasons Sleep Apnea Risk Jumps in Perimenopause (And Why It Goes Undiagnosed)
So many women in perimenopause are exhausted no matter how many hours they spend in bed, and the first assumption — from doctors and from themselves — is that it's just the hormones, just the night sweats, just the anxiety. The idea that their airway is actually collapsing dozens of times a night while they sleep never comes up. That gap between what's really happening and what gets investigated is the thing that bothers me most about how perimenopause is managed.
Learn more about Rose →Progesterone — the airway's best friend — starts disappearing first
Progesterone is a respiratory stimulant that actively maintains muscle tone in the upper airway, keeping the throat open during sleep. In perimenopause, progesterone levels decline earlier and more erratically than estrogen, removing this protective effect before most women even realize their hormones are shifting. Without it, the soft tissues of the throat are more likely to relax and collapse during sleep, creating the partial or complete obstructions that define obstructive sleep apnea.
Estrogen loss changes fat distribution around the neck and throat
Estrogen helps direct fat storage toward the hips and thighs; as it declines, fat redistributes toward the abdomen, chest, and neck — the same central pattern seen in men, who have significantly higher sleep apnea rates. Increased neck circumference is one of the strongest anatomical predictors of obstructive sleep apnea risk. This shift can happen gradually over years of perimenopause, meaning a woman's risk profile can change substantially without any dramatic weight gain overall.
Hot flashes and night sweats fragment sleep in ways that mimic apnea symptoms
The excessive daytime sleepiness, morning headaches, and poor concentration that characterize untreated sleep apnea are nearly identical to what women report from hot-flash-disrupted sleep. This symptomatic overlap gives clinicians — and women themselves — a convenient alternative explanation that delays investigation. Research has shown that women with frequent vasomotor symptoms are significantly more likely to have concurrent sleep-disordered breathing, suggesting the two conditions often coexist rather than one explaining away the other.
Screening tools were designed around male physiology and miss women routinely
The STOP-BANG questionnaire and similar screening tools were developed and validated primarily in male populations, where loud snoring and witnessed apnea events are the classic presentation. Women with sleep apnea more often report insomnia, depression, headaches, and fatigue — symptoms that score poorly on male-normed tools and point clinicians toward mood disorders instead. Studies have found that standard screening misses a substantial proportion of women with confirmed sleep apnea on polysomnography.
Women are far less likely to snore loudly, so the classic red flag is absent
Loud, disruptive snoring is the symptom most likely to prompt a sleep apnea referral — often because a bed partner reports it. Women with sleep apnea tend to have quieter, higher-pitched airway obstruction and more frequent arousals without full apnea events, a pattern called upper airway resistance syndrome that can cause significant sleep fragmentation with minimal snoring. A woman sleeping alone, or one whose partner hasn't noticed anything dramatic, has almost no chance of being flagged through the usual pathway.
Mood changes and anxiety make sleep apnea look like a mental health problem
Perimenopausal women presenting with irritability, low mood, anxiety, and cognitive difficulties are frequently assessed for depression and prescribed antidepressants before anyone considers whether chronic sleep deprivation from untreated apnea is driving the picture. Some antidepressants, particularly benzodiazepines used for anxiety, can actually worsen sleep apnea by relaxing upper airway muscles further. This creates a cycle where the underlying cause is never found and the treatments offered may make it worse.
Brain fog attributed to hormones may actually be oxygen deprivation
The cognitive symptoms of untreated sleep apnea — memory lapses, word-finding difficulty, slow processing, difficulty concentrating — overlap almost perfectly with the brain fog commonly attributed to estrogen fluctuation in perimenopause. Repeated nocturnal hypoxia, where blood oxygen drops during apnea events, has measurable effects on hippocampal function and cognitive performance. When a woman's brain fog doesn't improve with hormone therapy, untreated sleep apnea should be high on the list of alternative or contributing explanations.
Post-menopause risk catches up with men — suggesting hormones were protective all along
Before menopause, women have roughly one-third the sleep apnea prevalence of men the same age; after menopause, that gap closes dramatically, with post-menopausal women reaching near-parity with male rates when adjusted for BMI and age. This convergence is one of the clearest pieces of evidence that female sex hormones — particularly progesterone — provide genuine biological protection that disappears with the menopause transition. The trajectory means that a woman in her late 40s is moving along a steep upward curve of risk, not sitting at a stable baseline.
Untreated sleep apnea accelerates the cardiovascular risks already elevated by menopause
The menopause transition independently increases risk for hypertension, atrial fibrillation, and cardiovascular disease as estrogen's vasculoprotective effects decline. Obstructive sleep apnea adds its own cardiovascular burden through repeated cycles of hypoxia, surges in sympathetic nervous system activity, and oxidative stress — and the two risk factors together are not simply additive. Getting screened and treated matters beyond sleep quality: for perimenopausal women, missing a sleep apnea diagnosis may mean missing a meaningful piece of their long-term heart health picture.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.